Tutti gli studi
ReclutamentoFase IIInterventistico

Ketamine for the treatment of depression with anorexia nervosa

This study, called the EDEN project, is exploring if a medicine called ketamine can help people who have lived with anorexia nervosa for at least three years and also suffer from severe depression that hasn't responded to other treatments. Anorexia is a serious eating disorder, and depression often makes it harder to recover. While traditional antidepressants often don't work for this combination of conditions, ketamine is already used for depression in the UK. This trial will test a new form of ketamine or a dummy pill to see if it can improve depression, boost motivation, and help people on their journey to recovery. Participants will attend a series of in-person and online sessions over about six months.

A colpo d'occhio

Di cosa tratta questo studio?

Anorexia nervosa is a very serious eating disorder that can make people dangerously underweight and has a significant impact on health. Many people who have lived with anorexia for a long time also experience severe depression, which can make it even harder to get better. Unfortunately, the usual antidepressant medicines often don't help much when someone has both anorexia and depression.

This is why researchers are running the EDEN study. They want to see if a medication called ketamine, which is already used to treat depression in the UK, could be a new way to help. The idea is that if ketamine can lift depression, it might also give people more hope and motivation to work towards recovery from their anorexia.

This study hopes to find out if ketamine can improve the depressive symptoms in people with long-term anorexia, potentially opening up new treatment options for a condition that is currently very difficult to treat effectively. It's an important step towards finding better ways to support people facing these challenges.

Punti chiave

  • The study is for people with long-term anorexia nervosa and severe depression.
  • It aims to see if ketamine can improve depression and motivation for recovery.
  • Participation involves 13 sessions (in-person and online) over about 6 months.
  • You might receive ketamine or a dummy pill (placebo).
  • There's a chance it could help your depression, but no guarantee.
  • The study has specific health requirements and checks to ensure safety.

Chi può essere idoneo?

You might be able to join this study if you are 18 years or older and have been diagnosed with anorexia nervosa for at least three years. It's also important that you are currently experiencing severe depression, which hasn't improved even after trying at least one other treatment.

There are also some physical health checks: you need to weigh at least 40kg and have a Body Mass Index (BMI) of 14 or higher. The team will also check your general health, blood tests, and heart to make sure it's safe for you to take part. You must also be registered with a GP in the UK.

However, you won't be able to join if you've recently had heart problems like a stroke or heart attack, or have other serious health issues like uncontrolled high blood pressure or significant kidney or liver problems. The research team will review your medical history carefully to make sure the study is right and safe for you.

Questo studio potrebbe fare al caso tuo?

Rispondi a queste domande rapide per vedere se potresti essere idoneo. Questo è solo una guida — il team di ricerca prende la decisione finale.

  1. Hai 18 anni o più?
  2. Have you had anorexia nervosa for at least 3 years?
  3. Are you currently experiencing severe depression not helped by other treatments?
  4. Do you weigh at least 40kg and have a BMI of 14 or higher?
  5. Are you willing and able to attend study appointments in London?
  6. Do you have a GP in the UK that the study team can contact?
Rispondi a ogni domanda per vedere il tuo risultato.

Cosa comporta la partecipazione?

If you decide to take part, the study will last about six months and involve 13 sessions. First, you'll have an in-person screening visit to check if you're suitable. Then, there's an online session with some questionnaires and computer tasks.

The main part involves 8 in-person sessions where you will randomly receive either the study medication (ketamine) or a non-active dummy pill (placebo). No one, not even you or the study staff, will know which one you are taking. These sessions will be in the morning and last about 3 to 4 hours each. After these, you'll have one more in-person session for questionnaires, tasks, and a blood test, followed by two more online follow-up sessions with questionnaires and tasks.

Throughout the study, the team will closely monitor your health and well-being to ensure your safety.

Rischi e benefici potenziali

The main potential benefit of joining this study is that your depression might improve, which could then help you feel more motivated and hopeful about recovering from anorexia. However, as with any research study, there's no guarantee that you will personally benefit. It's also important to be aware that ketamine can have side effects, and some people might find the appointments and tests challenging or time-consuming. You can choose to leave the study at any time without giving a reason, and your regular medical care will not be affected. The study team will monitor your health very closely throughout your participation.

Luoghi (1)

  • King's College di Londra
    Approssimativo
    Londra, Regno Unito

Domande comuni

Che cos'è l'anoressia nervosa?

Anorexia nervosa is a serious eating disorder where people try to keep their weight as low as possible, often by restricting food, which can lead to severe health problems.

What is ketamine?

Ketamine is a medication that is used as an anaesthetic and, in lower doses, is also approved in the UK for treating severe depression.

Cosa significa 'placebo'?

A placebo is a 'dummy' pill that looks just like the real medicine but contains no active ingredient. It's used in studies to compare the effects of the active medicine.

Will I know if I'm getting ketamine or a placebo?

No, you won't. This is called 'blinding,' and it helps ensure the study results are fair and accurate. Neither you nor the study team will know until the study is over.

Where is the study taking place?

This study is being run from King's College London in the UK.

Come saperne di più

Johanna Keeler

Parla sempre con il tuo medico di base o specialista prima di decidere di partecipare a uno studio.

Interessato a partecipare?

Registrati per ricevere aggiornamenti

Condividi i tuoi dettagli e il team di ricerca per "Ketamine for the treatment of depression with anorexia nervo…" ti contatterà se potresti essere idoneo. Parla sempre con il tuo medico prima di accettare di partecipare.

Discussione

Discussione della comunità

Supportato dal nostro forum su community.patient.info. Si prega di essere rispettosi — questo non è un consiglio medico.